Sustainability Report RS26000

2024

DAU PRIVATE FOUNDATION

memoriaDAU2021-366791b0-03c2ec10_Página_03_Imagen_0002-721bb643
MANUFACTURING-6db29105
laboratoridau3

dau[34236]-fd0a452e

 

 

   Descriptive data on the organisation

VSME Ref. (CSRD-EU): A-B1.012

Corporate center.Headquarters of DAU PRIVATE FOUNDATION

Main activity center.

VSME Ref. (CSRD-EU): B1.006,,, B1.007, B1.010 - GRI Standard: 2-1, 2-6, 2-7, 2-8

Organization and activities

CORPORATE CENTER: Carrer C, 12-14 08040 Barcelona - No. of employees: 177
MAIN PLACE OF WORK: Same center (corporate/production) - No. of employees: 176
OTHER CENTERS | No. of workers | MAIN ACTIVITY:

Fundació Privada DAU's main purpose is to improve the quality of life of people with disabilities through individualized support and the creation of employment opportunities at Laboratori DAU and other companies in the region.

Within the framework of our strategic plan, we develop our work in two major strategic areas:

  1. Accompaniment and empowerment of people, through personalized itineraries of labor insertion, aimed at promoting their autonomy, personal development and integral wellbeing.
  2. Specialized management of Laboratori DAU, oriented to offer high quality services in the packaging of pharmaceutical products, cosmetics and food supplements for third parties.

Within this second area, Laboratori DAU develops a wide range of services, including:

  • Primary, secondary and tertiary conditioning of human and veterinary drugs.
  • Conditioning and analysis of investigational medicinal products (IMP).
  • Quality control analysis and certification of drug batches.
  • Import and export management of medicines.
  • Conditioning and analysis of cosmetic products and food supplements.

Our production plant has seven clean rooms for secondary drug packaging including EU serialization and four ISO 8 clean rooms (one of them with relative humidity conditions below 20%) for primary drug packaging, with temperature control (between 15-25 °C and 2-8 °C, depending on the requirements of each product) and relative humidity (RH) control. In addition, we have a label printing room, specifically dedicated to the packaging of Investigational Medicinal Products (IMP).

Through these areas of work, we reaffirm our commitment to unite technical excellence and social responsibility, contributing to the construction of a more inclusive, just and sustainable society, in which all people can develop their potential and contribute value to the common good.

 
ACTIVITY GROUP:  Pharmaceuticals, OTHER SERVICES, PRODUCT, MANUFACTURED PRODUCT, Food Products, SERVICES, HEALTH AND SOCIAL SERVICES
CNAE: 8899
Main families of products or services
 

Third-party services of secondary and tertiary conditioning of cosmetic products

Services to third parties for primary, secondary and tertiary packaging of marketed drugs and investigational drugs and food supplements.
Third party services of quality control, release, import and export of human, veterinary and investigational drugs.
Support services for the labor market integration of people with disabilities.
Vocational training services for people with disabilities

Production volumes per product/service family
VSME Ref. (CSRD-EU): C1.001

Secondary and tertiary conditioning service for cosmetic products.7.65 million Units

Primary, secondary and tertiary packaging services for drugs and investigational drugs and food supplements.9.48 million Units
Analysis, release, import and export of human, veterinary and investigational drugs.2,463 batches of commercial drugs AND LOT CERTIFICATIONS
Support services for the labor market integration of people with disabilities.: 384 people
Vocational training services for people with disabilities: 44 people

MAIN WEBSITE: www.fundaciodau.org / www.laboratoridau.com

Social information

class="img-responsive
 
class="img-responsive
 
class="img-responsive

Link here to our main social networks.

 

VSME Ref. (CSRD-EU): A-B1.006 - GRI Standard: 102-46 /

Scope of the Report Right Supply 26000 

RS26000 REPORT COVERAGE

Fundació Privada Dau

SCOPE:

The Fundació Privada DAU's fundamental mission is to improve the quality of life of people with disabilities through personalized support and the creation of job opportunities both in Laboratori DAU and in other companies in the region.

In line with this mission, our strategic plan is based on two main areas of action:

  1. Accompaniment and personal empowerment, aimed at facilitating the labor market insertion of people with disabilities, as a way to promote their autonomy, well-being and personal development.
  2. Integral management of Laboratori DAU, which includes the packaging of pharmaceutical products, cosmetics and medicines in the research phase for third parties, as well as specialized services for the quality control of medicines and the management of import processes. All of this is carried out under strict standards of quality and professional excellence, true to our firm social commitment.

Through these areas, we reinforce our purpose of building a more just, inclusive and sustainable society, where all people can develop their potential and contribute actively.

VSME Ref. (CSRD-EU): C2.002 - GRI Standard: 2-9, 2-12, 2-14

Governance

ESTRUCTURA DE GOBERNANZA: 

 

Fundació Privada DAU has a solid organizational structure that is committed to fulfilling its social mission.

The Board of Trustees, the Foundation's governing body, is composed of three professionals and three family members of users, all of whom are united by the desire to contribute to the development and sustainability of our mission. These are unpaid and voluntary positions, which bring experience, commitment and a diverse and complementary vision.

The General Management leads a six-member management team, together with section managers, technicians, assistants and operators, who work in a coordinated manner to ensure the smooth operation of all services and projects.

Within the framework of our 2022-2024 Strategic Plan, we initiated a process of organizational transformation aimed at adopting a more flexible and human governance model aligned with a higher purpose. This process seeks to strengthen our capacity to respond to social challenges, promoting a more agile, collaborative and people-centered structure.

The implementation of this new governance model is expected to take approximately three years, during which time work will be done to adapt the organizational culture, internal processes and mechanisms for participation and decision-making.

With this process, we reaffirm our commitment to evolve as an organization to continue offering quality services with a transforming social impact.

Ref. GRI Standard: 2-3

Contact regarding this report

CONTACT PERSON: Anna Cohí - Position: Dirección General

Direct phone: 0034 933000858 Mail: info@laboratoridau.com